It binds to TNFα and decreases its role in disorders involving excess inflammation in ankylosing spondylitis, adolescent rheumatoid arthritis, psoriasis, psoriatic arthritis, and rheumatoid arthritis and, potentially, in a variety of other disorders mediated by excess TNFα [9]. This evidence concerns the gene TNF and rheumatoid arthritis.